Application of double-negative T cells in haematological malignancies: recent progress and future directions

Haematologic malignancies account for a large proportion of cancers worldwide. The high occurrence and mortality of haematologic malignancies create a heavy social burden. Allogeneic haematopoietic stem cell transplantation is widely used in the treatment of haematologic malignancies. However, graft-versus-host disease and relapse after allogeneic haematopoietic stem cell transplantation are inevitable. An emerging treatment method, adoptive cellular therapy, has been effectively used in the treatment of haematologic malignancies. T cells, natural killer (NK) cells and tumour-infiltrating lymphocytes (TILs) all have great potential in therapeutic applications, and chimeric antigen receptor T (CAR-T) cell therapy especially has potential, but cytokine release syndrome and off-target effects are common. Efficient anticancer measures are urgently needed. In recent years, double-negative T cells (CD3 + CD4 − CD8 − ) have been found to have great potential in preventing allograft/xenograft rejection and inhibiting graft-versus-host disease. They also have substantial ability to kill various cell lines derived from haematologic malignancies in an MHC-unrestricted manner. In addition, healthy donor expanded double-negative T cells retain their antitumour abilities and ability to inhibit graft-versus-host disease after cryopreservation under good manufacturing practice (GMP) conditions, indicating that double-negative T cells may be able to be used as an off-the-shelf product. In this review, we shed light on the potential therapeutic ability of double-negative T cells in treating haematologic malignancies. We hope to exploit these cells as a novel therapy for haematologic malignancies.

• Publication year

  2022

• Venue

  Biomarker Research

• Publication date

  2022-03-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s40364-022-00360-wPMID 35287737PMCID 8919567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2022

  2022cited by this paper
• Cytokine Regulation and Function in T Cells.

  2021cited by this paper
• Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using Idelalisib

  2021cited by this paper
• T Cell Development: Old Tales Retold By Single-Cell RNA Sequencing.

  2021cited by this paper
• Restoration of HBV-specific CD8+ T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy

  2021cited by this paper
• Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production

  2021cited by this paper
• NKG2D Enhances Double-Negative T Cell Regulation of B Cells

  2021cited by this paper
• Transcriptome landscape of double negative T cells by single-cell RNA sequencing.

  2021influential reference
• Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy

  2021cited by this paper
• Venetoclax enhances T cell-mediated anti-leukemic activity by increasing ROS production.

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Recent advances and discoveries in the mechanisms and functions of CAR T cells

  2021cited by this paper
• CRISPR screen identifies genes that sensitize AML cells to double negative T cell therapy.

  2020cited by this paper
• Exploring the NK cell platform for cancer immunotherapy

  2020cited by this paper
• Side-effect management of chimeric antigen receptor (CAR) T-cell therapy.

  2020cited by this paper
• TCR‐α/β CD4− CD8− double negative T cells arise from CD8+ T cells

  2020cited by this paper
• Bone marrow niches in haematological malignancies

  2020cited by this paper
• CAR-NK cells: A promising cellular immunotherapy for cancer

  2020cited by this paper
• Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model

  2020cited by this paper
• DNT Cell-based Immunotherapy: Progress and Applications

  2020cited by this paper
• Global dynamics of healthy and cancer cells competing in the hematopoietic system.

  2020cited by this paper
• Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma.

  2020cited by this paper
• NK cells as adoptive cellular therapy for hematological malignancies: Advantages and hurdles.

  2020cited by this paper
• Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint blockade

  2019cited by this paper
• Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice

  2019cited by this paper
• Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity.

  2019cited by this paper
• Causes of double-negative T-cell lymphocytosis in children and adults

  2019cited by this paper
• Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention

  2019cited by this paper
• Next-generation regulatory T cell therapy

  2019cited by this paper
• NKG 2 D and DNAM-1 activating receptors and their ligands in NKT cell interactions : role in the NK cell-mediated negative regulation of T cell responses

  2019cited by this paper
• Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies

  2019cited by this paper
• Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors

  2019cited by this paper
• TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity

  2019cited by this paper
• Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity

  2019cited by this paper
• Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.

  2019cited by this paper
• Developing Allogeneic Double-Negative T Cells as a Novel Off-the-Shelf Adoptive Cellular Therapy for Cancer

  2019cited by this paper
• Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2.

  2019cited by this paper
• Antipancreatic cancer effect of DNT cells and the underlying mechanism.

  2019cited by this paper
• Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15

  2019cited by this paper
• Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2

  2019cited by this paper
• Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer.

  2019cited by this paper
• Adoptive Cell Therapy: ACT-Up or ACT-Out?

  2019cited by this paper
• Antibody-Mediated Rejection of Solid-Organ Allografts.

  2018cited by this paper
• Publisher's Note

  2018cited by this paper
• A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers

  2018cited by this paper
• Natural killer cells and other innate lymphoid cells in cancer

  2018cited by this paper
• Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy

  2018cited by this paper
• Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease

  2018cited by this paper
• Current Use and Trends in Hematopoietic Cell Transplantation in the United States.

  2017cited by this paper
• Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms

  2017cited by this paper
• HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities.

  2017cited by this paper
• DNT cell inhibits the growth of pancreatic carcinoma via abnormal expressions of NKG2D and MICA in vivo.

  2016cited by this paper
• CXCR5 is critically involved in progression of lupus through regulation of B cell and double‐negative T cell trafficking

  2016cited by this paper
• The biology of innate lymphoid cells

  2015cited by this paper
• Double Negative (DN) αβ T Cells: misperception and overdue recognition

  2015cited by this paper
• Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.

  2014cited by this paper
• NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses

  2013cited by this paper
• cAMP-responsive Element Modulator α (CREMα) trans-Represses the Transmembrane Glycoprotein CD8 and Contributes to the Generation of CD3+CD4−CD8− T Cells in Health and Disease*

  2013cited by this paper
• Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.

  2012cited by this paper
• Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy

  2011cited by this paper
• Fas death receptor signalling: roles of Bid and XIAP

  2011cited by this paper
• Characterization of CD3+CD4-CD8- (double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation.

  2011cited by this paper
• CD3+CD4-CD8- (double negative) T cells: saviours or villains of the immune response?

  2011cited by this paper
• Regulation of antigen‐expressing dendritic cells by double negative regulatory T cells

  2011cited by this paper
• Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression.

  2011cited by this paper
• Characterization of the immunoregulatory function of human TCR‐αβ+ CD4−CD8− double‐negative T cells

  2011cited by this paper
• Cell Therapy With Autologous Tolerogenic Dendritic Cells Induces Allograft Tolerance Through Interferon‐Gamma and Epstein‐Barr Virus‐Induced Gene 3

  2011cited by this paper
• Plasticity of CD4+ T cell lineage differentiation.

  2009cited by this paper
• Human TCR-αβ+ CD4− CD8− T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype1

  2009cited by this paper
• Normal mouse kidneys contain activated and CD3+CD4−CD8− double‐negative T lymphocytes with a distinct TCR repertoire

  2008cited by this paper
• Characterization of MHC class-I restricted TCRαβ+ CD4− CD8− double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination

  2008cited by this paper
• Double‐negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation

  2008cited by this paper
• Adoptive transfer of double negative T regulatory cells induces B‐cell death in vivo and alters rejection pattern of rat‐to‐mouse heart transplantation

  2008cited by this paper
• Cutting Edge: In Vivo Trogocytosis as a Mechanism of Double Negative Regulatory T Cell-Mediated Antigen-Specific Suppression1

  2008cited by this paper
• New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses.

  2007influential reference
• Double-Negative T Regulatory Cells Can Develop Outside the Thymus and Do Not Mature from CD8+ T Cell Precursors1

  2006cited by this paper
• Double-Negative T Cells, Activated by Xenoantigen, Lyse Autologous B and T Cells Using a Perforin/Granzyme-Dependent, Fas-Fas Ligand-Independent Pathway1

  2006cited by this paper
• CXCR5/CXCL13 Interaction Is Important for Double-Negative Regulatory T Cell Homing to Cardiac Allografts1

  2006cited by this paper
• Isolation and characterization of human antigen-specific TCRαβ+ CD4-CD8- double-negative regulatory T cells

  2005cited by this paper
• TCR Signal Strength Influences αβ/γδ Lineage Fate

  2005cited by this paper
• Characterization of a B220+ Lymphoid Cell Subpopulation with Immune Modulatory Functions in Nasal-Associated Lymphoid Tissues

  2005cited by this paper
• Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells.

  2005cited by this paper
• TCR signal strength influences alphabeta/gammadelta lineage fate.

  2005cited by this paper
• An architectural perspective on signaling by the pre‐, αβ and γδ T cell receptors

  2003cited by this paper
• Inhibition of Graft-Versus-Host Disease by Double-Negative Regulatory T Cells1

  2003cited by this paper
• Role of Double-Negative Regulatory T Cells in Long-Term Cardiac Xenograft Survival1

  2003cited by this paper
• Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice.

  2003cited by this paper
• Antitumor activity mediated by double-negative T cells.

  2003cited by this paper
• What is trogocytosis and what is its purpose?

  2003cited by this paper
• A Unique Population of Extrathymically Derived αβTCR+CD4−CD8− T Cells with Regulatory Functions Dominates the Mouse Female Genital Tract 1

  2003cited by this paper
• A unique population of extrathymically derived alpha beta TCR+CD4-CD8- T cells with regulatory functions dominates the mouse female genital tract.

  2003cited by this paper
• Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells.

  2002cited by this paper
• Ly‐6A is critical for the function of double negative regulatory T cells

  2002cited by this paper
• The nature and mechanisms of DN regulatory T-cell mediated suppression.

  2002cited by this paper
• CD4(-)CD8(-) regulatory T cells implicated in preventing graft-versus-host and promoting graft-versus-leukemia responses.

  2001cited by this paper
• Suppression of alloimmune responses in vitro and in vivo by CD3(+)CD8(-)CD4(-)alphabeta(+) regulatory T cells.

  2001cited by this paper
• Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression

  2000influential reference
• The primary site of CD4- 8- B220+ alphabeta T cells in lpr mice: the appendix in normal mice.

  1998cited by this paper
• Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

  1994cited by this paper
• Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.

  1992cited by this paper

• Uncovering the Hidden Players: Double-negative T Cells in Pediatric HIV and Their Impact on Disease Progression.

  2026cites this paper
• Immune reconstruction after allogeneic hematopoietic stem cell transplantation: rules, mechanisms, and applications.

  2026cites this paper
• Prognostic relevance of bone marrow immune cell fractions in newly diagnosed B-cell non-Hodgkin lymphoma patients

  2025cites this paper
• Elevated CD4- CD8- double-negative T cells in the peripheral blood of SFTS patients are associated with disease severity.

  2025cites this paper
• Unconventional T Cells’ Role in Cancer: Unlocking Their Hidden Potential to Guide Tumor Immunity and Therapy

  2025cites this paper
• Double negative T-cells in acute lymphoblastic leukemia: a pilot study in pediatric patients

  2025cites this paper
• The Emerging Roles and Therapeutic Potential of Unconventional T Cells in Sepsis

  2025influential citation
• Proinflammatory Phenotype of CD161+ Double-Negative T Cells

  2025cites this paper
• [Functional characterization of double-negative T cells isolated from leukoreduction filter residues].

  2025cites this paper
• Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia

  2025cites this paper
• [Double-negative αβ T lymphocytes: What are the etiological considerations?]

  2025cites this paper
• Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context

  2025cites this paper
• Characterization and effective expansion of CD4−CD8− TCRαβ+ T cells from individuals living with type 1 diabetes

  2024cites this paper
• Double-Negative T (DNT) Cells in Patients with Systemic Lupus Erythematosus

  2024cites this paper
• CAR Cells beyond Classical CAR T Cells: Functional Properties and Prospects of Application

  2024cites this paper
• Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review.

  2024cites this paper
• Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy

  2024cites this paper
• Universal CAR cell therapy: Challenges and expanding applications

  2024cites this paper
• Pharmacokinetic Positron Emission Tomography Imaging of an Optimized CD38-Targeted 68Ga-Labeled Peptide in Multiple Myeloma: A Pilot Study.

  2024cites this paper
• CAR beyond the classical CAR-T: functional features and application prospects (review)

  2024cites this paper
• Reconstitution of double-negative T cells after cord blood transplantation and its predictive value for acute graft-versus-host disease

  2023influential citation
• Chimeric antigen receptor T cells march into T cell malignancies

  2023cites this paper
• Preliminary analysis of double‐negative T, double‐positive T, and natural killer T‐like cells in B‐cell chronic lymphocytic leukemia

  2023cites this paper
• Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6

  2022cites this paper
• Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions.

  2022cites this paper